Keywords: خونریزی عمده; Direct oral anticoagulant; atrial fibrillation; major bleeding; stroke; systemic embolism;
مقالات ISI خونریزی عمده (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: خونریزی عمده; complications of catheter ablation; direct oral anticoagulant; pulmonary vein isolation; AF; atrial fibrillation; CI; confidence interval; CRNMB; clinically relevant nonmajor bleeding; DOACs; direct oral anticoagulants; MB; major bleeding; NOS; Newcastle-
Keywords: خونریزی عمده; AF; atrial fibrillation; ACT; activated clotting time; aPTT; activated partial thromboplastin time; b.i.d.; twice daily; dTT; diluted thrombin time; ECT; ecarin clotting time; FFP; fresh frozen plasma; FXa; factor X activated; INR; International Normalize
Keywords: خونریزی عمده; FFP; Fresh Frozen Plasma; FXa; factor X activated; INR; International Normalized Ratio; NOAC; non-vitamin K antagonist oral anticoagulant; PCC; prothrombin complex concentrate; PCCa; prothrombin complex concentrate activated; RBC; red blood cells; rFVIIa;
Keywords: خونریزی عمده; ACC/AHA; American College of Cardiology, American Heart Association; ACS; acute coronary syndrome(s); CABG; coronary artery bypass graft surgery; CAD; coronary artery disease; CV; cardiovascular; DAPT; dual antiplatelet therapy; ESC; European Society of C
Keywords: خونریزی عمده; Atrial fibrillation; Major bleeding; Restarting; Oral anticoagulant therapy;
Keywords: خونریزی عمده; Atrial fibrillation; Anticoagulation; Non-vitamin K antagonist oral anticoagulant; Warfarin; Stroke; Major bleeding;
Keywords: خونریزی عمده; Body mass index; CYP2C9; CYP4F2; Gene-environment interaction; Major bleeding; VKORC1; Warfarin;
Keywords: خونریزی عمده; atrial fibrillation; major bleeding; oral anticoagulants; postmarketing drug safety; aRR; adjusted relative risk; DOAC; direct oral anticoagulant;
Keywords: خونریزی عمده; Atrial fibrillation; Non-end-stage chronic kidney disease; Major bleeding; Warfarin; Direct oral anticoagulants; Atrial fibrillation; AF; Direct oral anticoagulants; DOACs; Chronic kidney disease; CKD; Non-end-stage chronic kidney disease; NECKD; Vitamin
Keywords: خونریزی عمده; antithrombotic; major bleeding; anticoagulant; antiplatelet; emergency department; intracranial haemorrhage
Keywords: خونریزی عمده; Gastrointestinal bleeding; ST-segment elevation myocardial infarction; Primary percutaneous coronary intervention; Major bleeding; Acute myocardial infarction;
Keywords: خونریزی عمده; Direct oral anticoagulants; Case fatality; VTE recurrence; Major bleeding; Vitamin K antagonists; Mortality;
Keywords: خونریزی عمده; Major bleeding; Orthopedic anesthesia; Peripheral nerve block; Retroperitoneal hematoma; Thromboprophylaxis
Non-vitamin K antagonists oral anticoagulants are as safe and effective as warfarin for cardioversion of atrial fibrillation: A systematic review and meta-analysis
Keywords: خونریزی عمده; AF; atrial fibrillation; CI; confidence interval; DCCV; direct current cardioversion; NOAC; non-vitamin K antagonist oral anticoagulant; OR; odds ratio; TEE; transesophageal echocardiography; TIA; transient ischemic attack; RCT; randomized controlled tria
Net clinical benefit of patent foramen ovale closure in patients with cryptogenic stroke: Meta-analysis and meta-regression of randomized trials
Keywords: خونریزی عمده; Stroke; Patent foramen ovale; Percutaneous closure; Major bleeding; Atrial fibrillation; Net clinical benefit;
Comparative effectiveness and safety of apixaban, dabigatran, and rivaroxaban in patients with non-valvular atrial fibrillation
Keywords: خونریزی عمده; DOAC; direct oral anticoagulant; NVAF; non-valvular atrial fibrillation; ATC; Anatomic Therapeutic Classification system; ICD-10; International Classification of Diseases version 10; HR; hazard ratio; CI; confidence interval; TIA; transient ischemic attac
Incidence, Determinants, and Outcomes of Left and Right Radial Access Use in Patients Undergoing Percutaneous Coronary Intervention in the United Kingdom
Keywords: خونریزی عمده; 30-day mortality; in-hospital mortality; in-hospital stroke; left radial access; MACE; major adverse cardiovascular event(s); major bleeding; right radial access; successive PCI; BCIS; British Cardiovascular Intervention Society; CABG; coronary artery byp
Characteristics and outcomes of reversed patients admitted to an emergency department for VKA-related intramuscular hematoma
Keywords: خونریزی عمده; Oral anticoagulant; VKA; Major bleeding; Intramuscular hematoma, ISTH criteria;
An updated meta-analysis of novel oral anticoagulants versus vitamin K antagonists for uninterrupted anticoagulation in atrial fibrillation catheter ablation
Keywords: خونریزی عمده; Atrial fibrillation; Catheter ablation; Novel oral anticoagulants; Vitamin K antagonists; Stroke; Major bleeding;
Major bleeding with vitamin K antagonists or direct oral anticoagulants in real-life
Keywords: خونریزی عمده; Anticoagulants; Major bleeding; Intracranial hemorrhage; Dabigatran; Rivaroxaban; Apixaban;
Full Length ArticleAnaemia as an independent key risk factor for major haemorrhage in patients treated with vitamin K antagonists: Results of the SCORE prospective cohort
Keywords: خونریزی عمده; Anaemia; Bleeding scores; Major bleeding; Vitamin K antagonists;
Balancing thromboembolic and bleeding risk with non-vitamin K antagonist oral anticoagulants (NOACs): A systematic review and meta-analysis on gender differences
Keywords: خونریزی عمده; Atrial fibrillation; Gender; Non-vitamin K antagonist oral anticoagulants; Stroke; Major bleeding;
Warfarin Initiation, Atrial Fibrillation, and Kidney Function: Comparative Effectiveness and Safety of Warfarin in Older Adults With Newly Diagnosed Atrial Fibrillation
Keywords: خونریزی عمده; Atrial fibrillation (AF); chronic kidney disease (CKD); warfarin; stroke; death; major bleeding; estimated glomerular filtration rate (eGFR); antithrombotic therapy; cardiovascular disease; kidney function; ischemic stroke; transient ischemic attack (TIA)
Non-Vitamin K Antagonist Oral Anticoagulants for Cardioversion in Atrial Fibrillation: An Updated Meta-analysis
Keywords: خونریزی عمده; Atrial fibrillation; Cardioversion; Major bleeding; Non-vitamin K antagonist oral anticoagulants; Stroke; Vitamin K antagonists;
Prothrombin complex concentrate administration for bleeding associated with non-vitamin K antagonist oral anticoagulants: The SAMURAI-NVAF study
Keywords: خونریزی عمده; VKA; Vitamin K antagonist; NOAC; Non-vitamin K antagonist oral anticoagulant; PCC; Prothrombin complex concentrate; SAMURAI; The Stroke Acute Management with Urgent Risk-factor Assessment and Improvement; NVAF; Nonvalvular atrial fibrillation; TIA; Transi
Predictive factors for bleeding during treatment with rivaroxaban and warfarin in Japanese patients with atrial fibrillation - Subgroup analysis of J-ROCKET AF
Keywords: خونریزی عمده; Atrial fibrillation; Major bleeding; Oral anticoagulation; Predictive factor; Stroke prevention;
CRUSADE bleeding score as a predictor of bleeding events in patients with acute coronary syndrome in Zagazig University Hospital
Keywords: خونریزی عمده; Acute coronary syndrome; Coronary artery disease; CRUSADE bleeding risk score; Major bleeding; Egypt;
Chronic Kidney Disease, Time in Therapeutic Range and Adverse Clinical Outcomes in Anticoagulated Patients with Non-valvular Atrial Fibrillation: Observations from the SPORTIF Trials
Keywords: خونریزی عمده; Non-valvular atrial fibrillation; Chronic kidney disease; Stroke; Major bleeding; Clinical outcomes
Coronary Thrombosis and Major Bleeding After PCI With Drug-Eluting Stents: Risk Scores From PARIS
Keywords: خونریزی عمده; bleeding; PCI; risk; thrombosis; CrCl; creatinine clearance; CTE; coronary thrombotic event; DAPT; dual-antiplatelet therapy; DES; drug-eluting stent(s); GOF; goodness-of-fit; MB; major bleeding; MI; myocardial infarction; OR; odds ratio; PCI; percutaneou
Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants After Cardioversion for Nonvalvular Atrial Fibrillation
Keywords: خونریزی عمده; Atrial fibrillation; Cardioversion; Major bleeding; Non-vitamin K antagonist oral anticoagulants; Stroke; Vitamin K antagonists;
Laparoscopic approach in a case of retroperitoneal and mesorectal haematoma following STARR procedure
Keywords: خونریزی عمده; STARR; Obstructed defecation syndrome; Major bleeding
HAS-BLED score predicts risk of in-hospital major bleeding in patients with acute non-ST segment elevation myocardial infarction
Keywords: خونریزی عمده; HAS-BLED; CRUSADE; ACUITY-HORIZONS; Major bleeding; NSTEMI;
Bivalirudin Versus Heparin Anticoagulation in Transcatheter Aortic Valve Replacement: The Randomized BRAVO-3 Trial
Keywords: خونریزی عمده; anticoagulation; bivalirudin; major bleeding; transcatheter aortic valve replacement; BARC; Bleeding Academic Research Consortium; CI; confidence interval; TAVR; transcatheter aortic valve replacement;
La puntuación SYNTAX predice hemorragias mayores tras implante de stents liberadores de fármacos en una población formada por pacientes consecutivos
Keywords: خونریزی عمده; Stent liberador de fármaco; Puntuación SYNTAX; Hemorragia mayor; Puntuación CRUSADE; Tratamiento antiagregante plaquetario combinado doble; Drug-eluting stent; SYNTAX score; Major bleeding; CRUSADE score; Dual antiplatelet therapy; ICP; intervención c
SYNTAX Score Predicts Major Bleeding Following Drug-eluting Stent Implantation in an All-comers Population
Keywords: خونریزی عمده; Drug-eluting stent; SYNTAX score; Major bleeding; CRUSADE score; Dual antiplatelet therapyStent liberador de fármaco; Puntuación SYNTAX; Hemorragia mayor; Puntuación CRUSADE; Tratamiento antiagregante plaquetario combinado dobleDAPT, dual antiplatelet the
Incidence, Source, Determinants, and Prognostic Impact of Major Bleeding in Outpatients With Stable Coronary Artery Disease
Keywords: خونریزی عمده; antiplatelet agent; coronary artery disease; major bleeding; oral anticoagulant; outcome; vitamin K antagonist; APT; antiplatelet therapy; BARC; Bleeding Academic Research Consortium; CAD; coronary artery disease; CIs; confidence intervals; eGFR; esti
Use of the CRUSADE Bleeding Risk Score in the Prediction of Major Bleeding for Patients with Acute Coronary Syndrome Receiving Enoxaparin in Thailand
Keywords: خونریزی عمده; CRUSADE risk score; Enoxaparin; Major bleeding; Acute coronary syndrome; Thailand
Prognostic Value of Access Site and Nonaccess Site Bleeding After Percutaneous Coronary Intervention : A Cohort Study in ST-Segment Elevation Myocardial Infarction and Comprehensive Meta-analysis
Keywords: خونریزی عمده; major bleeding; percutaneous coronary intervention; primary percutaneous coronary intervention; ST-segment elevation myocardial infarction; vascular access siteaPTT, activated partial thromboplastin time; ASB, access site bleeding; HR, hazard ratio; IABP,
The Prognostic Value of Bleeding Academic Research Consortium (BARC)-Defined Bleeding Complications in ST-Segment Elevation Myocardial Infarction : A Comparison With the TIMI (Thrombolysis In Myocardial Infarction), GUSTO (Global Utilization of Streptokin
Keywords: خونریزی عمده; major bleeding; primary percutaneous coronary intervention; ST-segment elevation myocardial infarctionaPTT, activated partial thromboplastin time; BARC, Bleeding Academic Research Consortium; CABG, coronary artery bypass graft; GUSTO, Global Utilization o
Concurrent Use of Warfarin and Antibiotics and the Risk of Bleeding in Older Adults
Keywords: خونریزی عمده; Antibiotics; Major bleeding; Older adults; Patient safety; Pharmacoepidemiology; Warfarin
Dabigatran, Rivaroxaban and Apixaban versus Enoxaparin for thomboprophylaxis after total knee or hip arthroplasty: Pool-analysis of phase III randomized clinical trials
Keywords: خونریزی عمده; venous thromboembolism; prophylaxis; new oral anticoagulants; enoxaparin; major bleeding; orthopedic surgery;
Short-Term Coagulation Complications Following Total Knee Arthroplasty : A Comparison of Patient-Reported and Surgeon-Verified Complication Rates
Keywords: خونریزی عمده; total knee arthroplasty; complications; deep vein thrombosis; pulmonary embolism; major bleeding; registry
Safety and efficacy of clopidogrel treatment in Japanese patients undergoing drug-eluting stent implantation
Keywords: خونریزی عمده; Clopidogrel; Major bleeding; Myocardial infarction; Percutaneous coronary intervention; Drug-eluting stent
Unprovoked Venous Thromboembolism: Short term or Indefinite Anticoagulation? Balancing Long-Term Risk and Benefit
Keywords: خونریزی عمده; Venous thromboembolism; Unprovoked; Oral anticoagulant therapy; Clinical decision rules; Recurrence; Major bleeding; Case-fatality rates